• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

FDA Places Clinical Hold On Foghorn Therapeutics' Early-Stage Blood Cancer Trial

Quote
cafead

cafead

Administrator
Staff member
  • cafead   May 20, 2022 at 10:52: AM
via The FDA has instituted a clinical hold on Foghorn Therapeutics Inc's Phase 1 dose-escalation study of FHD-286 in relapsed and/or refractory acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS).

article source
 

<



Similar threads

cafead
FDA places partial clinical hold on Zentalis’ trials of azenosertib for cancer
Replies
0
Views
15
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA places clinical hold on Arcellx’s multiple myeloma therapy trial
Replies
0
Views
178
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Magenta Down After FDA Places Clinical Hold on IND for AML/MDS Drug
Replies
0
Views
90
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA places clinical hold on Larimar’s rare disease drug after deaths in monkey study
Replies
0
Views
214
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
AbbVie stock down 0.8% after FDA places hold on clinical trials of venetoclax as a...
Replies
0
Views
127
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote